203 related articles for article (PubMed ID: 38147626)
1. High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
Stonestrom AJ; Menghrajani KN; Devlin SM; Franch-Expósito S; Ptashkin RN; Patel SY; Spitzer B; Wu X; Jee J; Sánchez Vela P; Milbank JH; Shah RH; Mohanty AS; Brannon AR; Xiao W; Berger MF; Mantha S; Levine RL
Blood Adv; 2024 Feb; 8(4):846-856. PubMed ID: 38147626
[TBL] [Abstract][Full Text] [Related]
2. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
Nowakowska MK; Kim T; Thompson MT; Bolton KL; Deswal A; Lin SH; Scheet P; Wehner MR; Nead KT
Am J Hematol; 2022 Apr; 97(4):411-420. PubMed ID: 35015316
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis and risk for hematologic malignancy.
Warren JT; Link DC
Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
[TBL] [Abstract][Full Text] [Related]
5. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract][Full Text] [Related]
6. How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling.
Beeler JS; Bolton KL
Leuk Res; 2023 Dec; 135():107419. PubMed ID: 37956474
[TBL] [Abstract][Full Text] [Related]
7. Causes and consequences of clonal hematopoiesis.
Weeks LD; Ebert BL
Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
[TBL] [Abstract][Full Text] [Related]
8. ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation.
Chan ICC; Panchot A; Schmidt E; McNulty S; Wiley BJ; Liu J; Turner K; Moukarzel L; Wong WSW; Tran D; Beeler JS; Batchi-Bouyou AL; Machiela MJ; Karyadi DM; Krajacich BJ; Zhao J; Kruglyak S; Lajoie B; Levy S; Patel M; Kantoff PW; Mason CE; Link DC; Druley TE; Stopsack KH; Bolton KL
Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38485690
[TBL] [Abstract][Full Text] [Related]
9. New Insights from Studies of Clonal Hematopoiesis.
Gibson CJ; Steensma DP
Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
[TBL] [Abstract][Full Text] [Related]
10. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
Ye B; Sheng Y; Zhang M; Hu Y; Huang H
Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
13. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
Zhang Z; Sun J
Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
15. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF
Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919
[TBL] [Abstract][Full Text] [Related]
16. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
[TBL] [Abstract][Full Text] [Related]
18. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
19. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
20. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
Goldman EA; Spellman PT; Agarwal A
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
